Key result
SCUBE1 levels did not significantly differ between patients with USAP, NSTEMI, STEMI, non-cardiac chest pain, and healthy controls (p=0.650), indicating it is not diagnostic for these conditions.
Why the study?
Does SCUBE1 measurement distinguish patients with unstable angina pectoris from those with NSTEMI and non-cardiac chest pain?
Population
230 individuals, comprising 185 patients presenting with chest pain or suspected acute coronary syndrome and…
Comparison
SCUBE1 biomarker measurement vs Routine laboratory parameters and comparison…
Design
Cross-sectional
Authors
Loading...
SCUBE1 should not guide ACS diagnosis in chest pain; leaves open the need for validated biomarkers in prospective studies.
Observational (n=230)
Does SCUBE1 measurement distinguish patients with unstable angina pectoris from those with NSTEMI and non-cardiac chest pain?
p-value: p=0.650
SCUBE1 is not a useful diagnostic biomarker for distinguishing unstable angina pectoris, NSTEMI, and STEMI from non-cardiac chest pain.
Özkan et al. (2017) conducted an observational in Acute coronary syndrome / Chest pain (n=230). SCUBE1 biomarker vs. Healthy controls was evaluated on Difference in SCUBE1 levels between patient groups and healthy controls (p=0.650). SCUBE1 levels did not significantly differ between patients with USAP, NSTEMI, STEMI, non-cardiac chest pain, and healthy controls (p=0.650), indicating it is not diagnostic for these conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: